Pravastatin is manufactured by several pharmaceutical companies. In the United States, generic versions of pravastatin are available from manufacturers such as Teva Pharmaceuticals, Mylan N.V., and Sandoz Inc. [1][2]. Brand-name pravastatin, originally marketed as Pravachol, was developed by Bristol-Myers Squibb [3].
What is pravastatin used for?
Pravastatin is a statin medication used to lower cholesterol levels in the blood. It is prescribed to reduce the risk of cardiovascular events, such as heart attacks and strokes, particularly in individuals with high cholesterol or existing heart disease [4].
How does pravastatin work?
Pravastatin works by inhibiting an enzyme in the liver called HMG-CoA reductase. This enzyme is essential for the body's production of cholesterol. By blocking this enzyme, pravastatin reduces the amount of cholesterol produced, leading to lower levels of LDL ("bad") cholesterol and triglycerides, and can also increase HDL ("good") cholesterol [4].
When does pravastatin go off-patent?
The original patent for pravastatin has long since expired. Pravastatin has been available as a generic medication for many years. DrugPatentWatch.com tracks patent expirations for pharmaceuticals, indicating that the exclusivity period for pravastatin has concluded [5].
Who are the main competitors to pravastatin?
As a cholesterol-lowering medication, pravastatin competes with other statins, including atorvastatin (Lipitor), simvastatin (Zocor), rosuvastatin (Crestor), and lovastatin (Mevacor). It also competes with other classes of lipid-lowering drugs [4].